BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17083107)

  • 1. Impact of radiotherapy on local recurrence of rectal cancer in Norway.
    Hansen MH; Kjaeve J; Revhaug A; Eriksen MT; Wibe A; Vonen B;
    Br J Surg; 2007 Jan; 94(1):113-8. PubMed ID: 17083107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inadvertent perforation during rectal cancer resection in Norway.
    Eriksen MT; Wibe A; Syse A; Haffner J; Wiig JN; ;
    Br J Surg; 2004 Feb; 91(2):210-6. PubMed ID: 14760670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
    Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B
    Br J Surg; 2005 Feb; 92(2):225-9. PubMed ID: 15609382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E; Putter H; van de Velde CJ;
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer.
    Martling A; Cedermark B; Johansson H; Rutqvist LE; Holm T
    Br J Surg; 2002 Aug; 89(8):1008-13. PubMed ID: 12153626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.
    Arnaud JP; Nordlinger B; Bosset JF; Boes GH; Sahmoud T; Schlag PM; Pene F
    Br J Surg; 1997 Mar; 84(3):352-7. PubMed ID: 9117306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally recurrent rectal cancer in Norway.
    Hansen MH; Balteskard L; Dørum LM; Eriksen MT; Vonen B;
    Br J Surg; 2009 Oct; 96(10):1176-82. PubMed ID: 19787766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence and survival after mesorectal excision for rectal cancer.
    Bülow S; Christensen IJ; Harling H; Kronborg O; Fenger C; Nielsen HJ; ;
    Br J Surg; 2003 Aug; 90(8):974-80. PubMed ID: 12905551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer.
    Manfredi S; Benhamiche AM; Meny B; Cheynel N; Rat P; Faivre J
    Br J Surg; 2001 Sep; 88(9):1221-7. PubMed ID: 11531871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative staging of rectal cancer allows selection of patients for preoperative radiotherapy.
    Horgan AF; Finlay IG
    Br J Surg; 2000 May; 87(5):575-9. PubMed ID: 10792312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
    Wu AW; Gu J; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of primary locally advanced rectal cancer in Norway.
    Eriksen MT; Wibe A; Hestvik UE; Haffner J; Wiig JN; ;
    Eur J Surg Oncol; 2006 Mar; 32(2):174-80. PubMed ID: 16412603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of total mesorectal excision on the results of surgery of distal rectal cancer.
    Law WL; Chu KW
    Br J Surg; 2001 Dec; 88(12):1607-12. PubMed ID: 11736973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy.
    Holm T; Johansson H; Cedermark B; Ekelund G; Rutqvist LE
    Br J Surg; 1997 May; 84(5):657-63. PubMed ID: 9171755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based study of local surgery for rectal cancer.
    Folkesson J; Johansson R; Påhlman L; Gunnarsson U
    Br J Surg; 2007 Nov; 94(11):1421-6. PubMed ID: 17661311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery at a national level.
    Wibe A; Eriksen MT; Syse A; Tretli S; Myrvold HE; Søreide O;
    Br J Surg; 2005 Feb; 92(2):217-24. PubMed ID: 15584060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
    Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
    J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.